We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
-2.39%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$384M
AUM Growth
-$58.3M
(-13%)
Cap. Flow
-$20.7M
Cap. Flow
% of AUM
-5.39%
Top 10 Holdings %
Top 10 Hldgs %
77.1%
Holding
69
New
5
Increased
21
Reduced
13
Closed
13
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$5.71M |
| 2 |
Arrowhead Research
ARWR
|
+$4.52M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$3.87M |
| 4 |
Immunovant
IMVT
|
+$1.51M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$1.47M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$8.11M |
| 2 |
NuScale Power
SMR
|
+$6.45M |
| 3 |
Snowflake
SNOW
|
+$4.58M |
| 4 |
IONQ.WS
IonQ Inc Warrants
IONQ.WS
|
+$3.9M |
| 5 |
Merck
MRK
|
+$2.94M |
Sector Composition
| 1 | Consumer Discretionary | 29.62% |
| 2 | Technology | 24.05% |
| 3 | Healthcare | 23.5% |
| 4 | Communication Services | 20.98% |
| 5 | Energy | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coupang
CPNG
$31.8B
| $1.83M | 0.48% |
81,900
-60,000
| -42% | -$1.39M |
|
|
27
Alnylam Pharmaceuticals
ALNY
$37.6B
| $1.54M | 0.4% |
+5,716
| New | +$1.47M |
|
28
Krystal Biotech
KRYS
$10B
| $1.35M | 0.35% |
7,510
-1,740
| -19% | -$293K |
|
29
Roivant Sciences
ROIV
$25.1B
| $1.28M | 0.33% |
126,923
-88,583
| -41% | -$958K |
|
|
30
Immunovant
IMVT
$7.96B
| $1.23M | 0.32% |
+72,000
| New | +$1.51M |
|
31
UroGen Pharma
URGN
$1.91B
| $1.19M | 0.31% |
107,622
+79,931
| +289% | +$852K |
|
|
RNAM
32
DELISTED
Avidity Biosciences
RNAM
| $1.02M | 0.27% |
34,500
+2,600
| +8% | +$81K |
|
33
Wave Life Sciences
WVE
$1.18B
| $917K | 0.24% |
113,550
+25,550
| +29% | +$279K |
|
34
Pfizer
PFE
$138B
| $819K | 0.21% |
32,327
+10,349
| +47% | +$271K |
|
35
Valaris
VAL
$5.44B
| $794K | 0.21% |
20,222
+6,040
| +43% | +$259K |
|
36
MeiraGTx Holdings
MGTX
$1.15B
| $793K | 0.21% |
117,000
-108,078
| -48% | -$726K |
|
37
NOV
NOV
$6.93B
| $757K | 0.2% |
49,745
+6,856
| +16% | +$103K |
|
38
Recursion Pharmaceuticals
RXRX
$1.77B
| $630K | 0.16% |
119,000
| – | – |
|
39
American International
AIG
$41.9B
| $564K | 0.15% |
6,483
-1,541
| -19% | -$120K |
|
40
Lexeo Therapeutics
LXEO
$363M
| $556K | 0.14% |
160,198
+22,083
| +16% | +$97.8K |
|
41
Pan American Silver
PAAS
$18.3B
| $550K | 0.14% |
21,284
| – | – |
|
|
SA
42
Seabridge Gold
SA
$2.78B
| $514K | 0.13% |
44,074
+8,087
| +22% | +$95.9K |
|
|
EMX
43
DELISTED
EMX Royalty
EMX
| $443K | 0.12% |
216,968
| – | – |
|
|
VZLA
44
Vizsla Silver
VZLA
$1.12B
| $437K | 0.11% |
192,487
+75,966
| +65% | +$160K |
|
45
4D Molecular Therapeutics
FDMT
$612M
| $423K | 0.11% |
131,000
+10,000
| +8% | +$47.1K |
|
46
Intellia Therapeutics
NTLA
$1.86B
| $417K | 0.11% |
58,709
+31,000
| +112% | +$313K |
|
47
Sprott Uranium Miners ETF
URNM
$1.86B
| $393K | 0.1% |
12,114
+1,838
| +18% | +$69.8K |
|
|
AUTL
48
Autolus Therapeutics
AUTL
$386M
| $390K | 0.1% |
251,674
+20,000
| +9% | +$40.6K |
|
49
Noble Corp
NE
$6.65B
| $339K | 0.09% |
14,287
+3,762
| +36% | +$108K |
|
50
ALX Oncology
ALXO
$269M
| $317K | 0.08% |
509,059
| – | – |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM